The supply of a plant-derived anti-cancer drug can finally meet global demand after a team of scientists from Denmark and the U.S. engineered yeast to produce the precursor molecules, which could previously only be obtained in trace concentrations in the native plant. A study describing the breakthrough was recently published in Nature. The international team included four researchers from the Biological Systems and Engineering Division: Leanne Jade G. Chan, Edward Baidoo, Christopher J. Petzold, and Jay D. Keasling.
Was this page useful?
Send
![like](https://biosciences.lbl.gov/wp-content/plugins/lbl-feedback/assets/thumb_up.png)
![not like](https://biosciences.lbl.gov/wp-content/plugins/lbl-feedback/assets/thumb_down.png)